Arthritis, Reactive D016918

Related MeSH Hierarchy (5)

Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Spinal Diseases » Spondylitis » Spondylarthritis » Spondylarthropathies » Arthritis, Reactive

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Arthritis, Infectious » Arthritis, Reactive

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Spondylarthritis » Spondylarthropathies » Arthritis, Reactive

Diseases [C] » Infections [C01] » Arthritis, Infectious » Arthritis, Reactive

Description

An aseptic, inflammatory arthritis developing secondary to a primary extra-articular infection, most typically of the GASTROINTESTINAL TRACT or UROGENITAL SYSTEM. The initiating trigger pathogens are usually SHIGELLA; SALMONELLA; YERSINIA; CAMPYLOBACTER; or CHLAMYDIA TRACHOMATIS. Reactive arthritis is strongly associated with HLA-B27 ANTIGEN.   MeSH

Approved Indicated Drugs (1)

Phase 1 Indicated Drugs (1)

Other Experimental Indicated Drugs (3)


Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.